Form 4: HCA Healthcare Executive Acquires Stock Appreciation Rights and Disposes of Shares

HCA Healthcare's EVP & Chief Legal & Admin Officer, Michael R. McAlevey, acquired stock appreciation rights and disposed of common stock, according to a recent SEC filing.

Summary

• Michael R. McAlevey, EVP & Chief Legal & Admin Officer at HCA Healthcare, filed a Form 4 with the SEC.
• The filing details transactions including the disposal of 1,110 shares of common stock and the acquisition of 11,171 stock appreciation rights.
• The stock appreciation rights have an exercise price of $328.70 and vest in four equal annual installments starting January 28, 2026.
• The filing also indicates that McAlevey indirectly owns 2,902 shares through a 2024 GRAT and 26 shares through a managed account.
• McAlevey disclaims beneficial ownership of the shares held in the managed account except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions by an executive, with no inherent positive or negative sentiment.

Future Outlook

The stock appreciation rights vest over four years, starting in 2026, which could incentivize long-term performance.

Industry Context

This filing is a routine disclosure of executive compensation and stock transactions, common in the healthcare industry.

Comparison to Industry Standards

• Executive compensation packages often include stock options and stock appreciation rights to align management interests with shareholder value.
• The vesting schedule of the stock appreciation rights is typical for executive compensation plans.
• The reporting of these transactions is standard practice for publicly traded companies like HCA Healthcare.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it is a standard executive compensation disclosure.

Key Dates

Keywords

HCA Healthcare, Stock Appreciation Rights, SEC Form 4, Executive Compensation, Insider Trading, Michael R. McAlevey, Equity Securities